Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Hanover - Delayed Quote EUR

Abbott Laboratories (ABL.HA)

Compare
116.50
-3.14
(-2.62%)
At close: April 4 at 5:25:27 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
41,950,000
41,950,000
40,109,000
43,653,000
43,075,000
Cost of Revenue
18,706,000
18,706,000
17,975,000
19,142,000
18,537,000
Gross Profit
23,244,000
23,244,000
22,134,000
24,511,000
24,538,000
Operating Expense
16,419,000
16,419,000
15,656,000
16,149,000
16,113,000
Operating Income
6,825,000
6,825,000
6,478,000
8,362,000
8,425,000
Net Non Operating Interest Income Expense
-215,000
-215,000
-252,000
-375,000
-490,000
Other Income Expense
403,000
403,000
438,000
319,000
276,000
Pretax Income
7,013,000
7,013,000
6,664,000
8,306,000
8,211,000
Tax Provision
-6,389,000
-6,389,000
941,000
1,373,000
1,140,000
Net Income Common Stockholders
13,402,000
13,402,000
5,723,000
6,933,000
7,071,000
Diluted NI Available to Com Stockholders
13,402,000
13,402,000
5,723,000
6,933,000
7,071,000
Basic EPS
7.67
--
3.28
3.94
4.01
Diluted EPS
7.64
--
3.26
3.91
3.94
Basic Average Shares
1,740,000
--
1,740,000
1,753,000
1,764,082.19
Diluted Average Shares
1,748,000
--
1,749,000
1,764,000
1,789,000
Total Operating Income as Reported
6,825,000
6,825,000
6,478,000
8,362,000
8,425,000
Total Expenses
35,125,000
35,125,000
33,631,000
35,291,000
34,650,000
Net Income from Continuing & Discontinued Operation
13,402,000
13,402,000
5,723,000
6,933,000
7,071,000
Normalized Income
13,380,670
13,380,670
5,758,219
6,934,669.40
7,071,861
Interest Income
344,000
344,000
385,000
183,000
43,000
Interest Expense
559,000
559,000
637,000
558,000
533,000
Net Interest Income
-215,000
-215,000
-252,000
-375,000
-490,000
EBIT
7,572,000
7,572,000
7,301,000
8,864,000
8,744,000
EBITDA
10,790,000
10,790,000
10,544,000
12,131,000
12,282,000
Reconciled Cost of Revenue
17,366,000
17,366,000
16,698,000
17,888,000
17,046,000
Reconciled Depreciation
3,218,000
3,218,000
3,243,000
3,267,000
3,538,000
Net Income from Continuing Operation Net Minority Interest
13,402,000
13,402,000
5,723,000
6,933,000
7,071,000
Total Unusual Items Excluding Goodwill
27,000
27,000
-41,000
-2,000
-1,000
Total Unusual Items
27,000
27,000
-41,000
-2,000
-1,000
Normalized EBITDA
10,763,000
10,763,000
10,585,000
12,133,000
12,283,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5,670
5,670
-5,781
-330.60
-139
12/31/2021 - 11/5/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

I25.F iRhythm Technologies, Inc.
88.00
-2.76%
 
1BSX.MI Boston Scientific Corporation
84.00
-5.62%
 
NYZ.BE Novacyt SA
0.4560
-7.69%
 
CRBX.ST Carbiotix AB
11.50
-1.29%
 
BIOV.TA Bio-View Ltd
28.00
0.00%
 
WLSI Wellstar International, Inc.
0.0000
0.00%
 
NEOLA.ST Neola Medical AB (publ)
2.7800
+5.30%
 
SUN.L Surgical Innovations Group plc
0.5500
0.00%
 
7AC.F Acarix AB (publ)
0.0190
-1.04%
 
EPIS-B.ST Episurf Medical AB (publ)
0.1158
-4.61%